Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study-Reference-Cited by-同舟云学术

Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study

Published:2023-04 Issue:4 Volume:86 Page:412-414
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Kang Sung-Woon,Kim Jun-Won,Kim Ji Yeun^ORCID,Lim So Yun,Jang Choi-Young,Chang Euijin^ORCID,Yang Jeong-Sun,Kim Kyung-Chang,Jang Hee-Chang,Kim Dasol,Shin Younmin,Lee Joo-Yeon,Kim Sung-Han^ORCID

Funder

Korea National Institute of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. The duration of infectiousness of individuals infected with SARS-CoV-2;Walsh;J Infect,2020

2. Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies;Chen;J Infect,2022

3. Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection;Kang;J Infect,2022

4. Clinical scoring system to predict viable viral shedding in patients with COVID-19;Kang;J Clin Virol,2022

5. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19);van Kampen;Nat Commun,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19;CMI Communications;2024-12

2. Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee;Current Research in Translational Medicine;2024-09

3. SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening;SLAS Discovery;2024-09

4. Stuck in pandemic uncertainty: a review of the persistent effects of COVID-19 infection in immune-deficient people;Clinical Microbiology and Infection;2024-08

5. Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study;2024-07-15